Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Seksuel dysfunktion i menopausen. Status over forekomst, farmakologiske behandlingsmuligheder og risici

Research output: Contribution to journalReviewResearchpeer-review

  1. Kirurgisk behandling ved kvindelig infertilitet

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Surfactant therapy of respiratory distress syndrome

    Research output: Contribution to journalReviewResearchpeer-review

  3. DBCG Kvalitetsdatabase for Brystkræft – resumé af årsrapport 2020

    Research output: Contribution to journalJournal articleCommunication

  4. Nærdødsoplevelser

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Hjertestop hos en patient med langt QT-syndrom i androgendeprivationsterapi

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hyperseksualitet

    Research output: Contribution to journalJournal articleCommunication

  2. Sexual Health and Dysfunction in Patients With Rheumatoid Arthritis: A Cross-sectional Single-Center Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The frequency of female sexual dysfunction increases with age, and the menopause has a negative influence on sexual life. Pharmacological treatment options of female sexual dysfunctions in the menopause include hormone therapy and sildenafil. Few randomised controlled studies have been done, and there is evidence suggesting that systemic hormone therapy, such as estrogen, estrogen/progesterone, estrogen/testosterone and tibolone, has a positive impact on sexual dysfunction in the menopause. There is evidence that local estrogen relieves vaginal dryness and dyspareunia. The recent discoveries of the side effects of hormone therapy necessitate careful evaluation of the indication for hormone therapy, and the duration of treatment is recommended to be as short as possible. The long-term side effects of testosterone in women have not yet been fully investigated. Sildenafil has shown a positive effect on female sexual dysfunction only in a limited group of women: those with arousal problems without desire problems. This result demands a focus on new pharmaceutical products, and at present the effect of testosterone and selective estrogen receptor modulators on female sexual dysfunction is being investigated.

Translated title of the contributionSexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects
Original languageDanish
JournalUgeskrift for Laeger
Volume168
Issue number6
Pages (from-to)559-63
Number of pages5
ISSN0041-5782
Publication statusPublished - 6 Feb 2006

ID: 55814482